Nano Labs Ltd. Files Interim Balance Sheet
Ticker: NA · Form: 6-K · Filed: Nov 21, 2024 · CIK: 1872302
Sentiment: neutral
Topics: financial-reporting, balance-sheet, interim-report
TL;DR
Nano Labs dropped its Q3 balance sheet, unaudited but management-prepared.
AI Summary
Nano Labs Ltd. filed a Form 6-K on November 21, 2024, reporting its interim condensed balance sheet as of September 30, 2024. The financial statements were prepared by the company's management and are unaudited.
Why It Matters
This filing provides a snapshot of Nano Labs Ltd.'s financial position as of September 30, 2024, offering insight into its assets, liabilities, and equity.
Risk Assessment
Risk Level: low — This is a routine financial filing (6-K) that provides an interim balance sheet, not a significant event like an acquisition or major operational change.
Key Numbers
- September 30, 2024 — Balance Sheet Date (This is the date for which the financial position is reported.)
Key Players & Entities
- Nano Labs Ltd (company) — Filer of the report
- September 30, 2024 (date) — Date of the interim condensed balance sheet
- November 21, 2024 (date) — Filing date of the 6-K
FAQ
What is the purpose of this Form 6-K filing?
The purpose of this Form 6-K filing is to report the interim condensed balance sheet of Nano Labs Ltd. as of September 30, 2024.
Who prepared the interim condensed balance sheet?
The interim condensed balance sheet as of September 30, 2024, was prepared by the Company's management.
Are the financial statements in this filing audited?
No, the interim condensed balance sheet as of September 30, 2024, is preliminary and unaudited.
What is the filing date of this report?
This Form 6-K report was filed on November 21, 2024.
What is the principal executive office location for Nano Labs Ltd?
The principal executive offices are located at China Yuangu Hanggang Technology Building 509 Qianjiang Road, Shangcheng District, Hangzhou, Zhejiang, 310000, People's Republic of China.
Filing Stats: 930 words · 4 min read · ~3 pages · Grade level 17.4 · Accepted 2024-11-21 16:00:11
Key Financial Figures
- $1 — 22 * Convenient translation rate is US$1 = RMB7.0074 1 In accordance with Nas
- $2.5 million — ny is required to maintain a minimum of $2.5 million in stockholders’ equity for conti
- $8.5 million — he Lenders in an aggregated amount of US$8.5 million into certain amount of Class A ordinary
Filing Documents
- ea0222145-6k_nanolabs.htm (6-K) — 39KB
- 0001213900-24-100969.txt ( ) — 40KB
Forward-Looking Statements
Forward-Looking Statements This report contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements include, without limitation, the Company’s compliance with the relevant Nasdaq continued listing standards, which can be identified by terminology such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions. Such statements are based upon management’s current expectations and current market and operating conditions, and relate to events that involve known or unknown risks, uncertainties and other factors, all of which are difficult to predict and many of which are beyond the Company’s control, which may cause the Company’s compliance status, actual results, performance or achievements to differ materially from those in the forward-looking statements. Further information regarding these and other risks, uncertainties or factors is included in the Company’s filings with the SE C . The Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under law. 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Nano Labs Ltd Date: November 21, 2024 By: /s/ Jianping Kong Name: Jianping Kong Title: Chairman and Chief Executive Officer 3